The U.S. Food and Drug Administration (FDA) has approved Biktarvy (bictegravir 50mg/emtricitabine 200mg/tenofovir alafenamide 25mg, BIC/FTC/TAF), a once-daily single tablet
Category: Hepatitis B
Virus cracking molecules for treating Hepatitis B
Indiana University researchers have made an important step forward in the design of drugs that fight the hepatitis B virus,
Mavyret for treating chronic hepatitis C
Mavyret is a prescription medicine used to treat adults with chronic hepatitis C virus HCV genotypes 1, 2, 3, 4,
Treatment and prevention of cancer
Treatment of cancer depends on the type and stage of the cancer. Age and health status of the patients will
